Company News »
Arrowhead to Present at Jefferies 2015 Healthcare Conference
Arrowhead Research Corporation (NASDAQ:ARWR) , a biopharmaceutical company developing targeted RNAi therapeutics, today announced that Arrowhead’s president and chief executive officer Christopher Anzalone, Ph.D., will present a corporate overview at the Jefferies 2015 Healthcare Conference on June 3, 2015 at 10:00 a.m. EDT.
Investors may access live and archived versions of the audio webcast of this presentation on the Events and Presentations page of the Company’s website at http://ir.arrowheadresearch.com/events.cfm.
About Arrowhead Research Corporation
Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary Dynamic Polyconjugate delivery platform to develop targeted drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Arrowhead’s pipeline includes ARC-520 for chronic hepatitis B virus and ARC-AAT for liver disease associated with Alpha-1 antitrypsin deficiency.
For more information please visit http://www.arrowheadresearch.com, or follow us on Twitter @ArrowRes. To be added to the Company’s email list and receive news directly, please visit http://ir.arrowheadresearch.com/alerts.cfm.
Source: Arrowhead Research Corporation
View source version on businesswire.com: http://www.businesswire.com/news/home/20150527005435/en/
- Sterling Bounces After Solid Production and Retail Data 10 views
- GE Appliances and Keurig(R) Brew Up the Next Big Thing in Refrigeration 3 views
- New USG Packaging, Same Great USG Products 2 views
- Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent 2 views
- On Assignment Closes Acquisition of Creative Circle 2 views
- US Productivity Falls 2 views
- ECA Medical Instruments Develops First Disposable Spinal Instrument Fixation Kit to Gain FDA Approval with Intelligent Implant Systems 2 views
- USD/CAD Tests Support as Negative Momentum Accelerates 2 views
- What’s the Story With the Sears Holdings-Simon Properties Deal? 2 views
- Guidance Software Awarded 5-Star Rating in CRN’s 2015 Partner Program Guide 1 view
| Forex Broker Spreads » |
|
Iron FX
XM Markets
FxPro
FXCM| Most Popular Articles » |
- Sterling Bounces After Solid Production and Retail Data 10 views
- GE Appliances and Keurig(R) Brew Up the Next Big Thing in Refrigeration 3 views
- ECA Medical Instruments Develops First Disposable Spinal Instrument Fixation Kit to Gain FDA Approval with Intelligent Implant Systems 2 views
- USD/CAD Tests Support as Negative Momentum Accelerates 2 views
- What’s the Story With the Sears Holdings-Simon Properties Deal? 2 views
- New USG Packaging, Same Great USG Products 2 views
- Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent 2 views
- On Assignment Closes Acquisition of Creative Circle 2 views
- US Productivity Falls 2 views
- Italy Hit With Unemployment And Inflation Blows 1 view